An overview of the management of osteoporosis in the aging female population

U Amin, A McPartland, M O'Sullivan… - Women's Health, 2023 - journals.sagepub.com
Osteoporosis is a systemic skeletal disease that is a cause of morbidity and mortality. It can
affect all ages but most frequently postmenopausal women. It is a silent condition, however …

Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis

YG Chiu, CT Ritchlin - Expert opinion on biological therapy, 2017 - Taylor & Francis
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by
focal pathologic bone resorption due to excessive activity of osteoclasts (OC). Receptor …

Effect of agents affecting bone homeostasis on short‐and long‐term implant failure

J Jung, JI Ryu, GJ Shim… - Clinical oral implants …, 2023 - Wiley Online Library
Objectives To review the current evidence on the relationship between agents that affect
bone homeostasis and dental implant failures. Materials and Methods Electronic searches …

Denosumab in chronic kidney disease: a narrative review of treatment efficacy and safety

A Gopaul, T Kanagalingam, J Thain, T Khan… - Archives of …, 2021 - Springer
People with chronic kidney disease (CKD) are at high risk of bone fractures. In this review,
we summarize the complexity of fracture prevention in CKD, describe the usefulness of a …

Effects of PTH and PTH hypersecretion on bone: a clinical perspective

L Rejnmark, H Ejlsmark-Svensson - Current osteoporosis reports, 2020 - Springer
Abstract Purpose of Review Hyperparathyroidism may be due to an autonomous
hypersecretion of parathyroid hormone (PTH) or occurs in response to a number of …

Comparative safety and effectiveness of denosumab versus zoledronic acid in patients with osteoporosis: a cohort study

NK Choi, DH Solomon, TN Tsacogianis… - Journal of Bone and …, 2017 - academic.oup.com
Limited head‐to‐head comparative safety and effectiveness data exist between denosumab
and zoledronic acid in real‐world healthcare. We aimed to examine the safety and …

Osteoporosis in patients with respiratory diseases

Y Ma, S Qiu, R Zhou - Frontiers in physiology, 2022 - frontiersin.org
Climate change, environmental pollution, and virus epidemics have sharply increased the
number of patients suffering from respiratory diseases in recent years. Prolonged periods of …

The osteoprotective effects of artemisinin compounds and the possible mechanisms associated with intracellular iron: A review of in vivo and in vitro studies

J Zhang - Environmental Toxicology and Pharmacology, 2020 - Elsevier
Osteoporosis is a progressive systemic disease characterized by low bone mineral density
and deterioration of bone microarchitecture. The current therapies are effective to prevent …

Adverse events associated with bone-directed therapies in patients with cancer

MA Jara, J Varghese, MI Hu - Bone, 2022 - Elsevier
Bone metastatic disease may lead to serious adverse events in patients with cancer. Bone-
directed therapies, including bisphosphonates such as pamidronate and zoledronic acid …

The role of neoadjuvant denosumab in the treatment of aneurysmal bone cysts: a case series and review of the literature

AM Giantini-Larsen, VB Chakravarthy… - Journal of …, 2022 - thejns.org
OBJECTIVE Aneurysmal bone cysts (ABCs) are benign cystic lesions most commonly
occurring in the long bones of pediatric patients. Spinal ABCs may be difficult to resect given …